Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells

Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway

(2018) Ying Lu et al.   Cell Death & Disease

Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells

(2017) Zhuo Yao et al.   Cell Death & Disease

Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia

(2017) Huilin Huang et al.   Scientific Reports

Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells

(2017) Yuan Zhang et al.   SAUDI JOURNAL OF BIOLOGICAL SCIENCES

Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway

(2017) Zhijie Xu et al.   PLoS One

A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5

(2016) Jing Wu et al.   CANCER LETTERS

Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 Interaction

(2016) Qinghao Zhang et al.   PLoS One

Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update

(2016) Arif Malik et al.   Analytical Cellular Pathology

Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms

(2016) Min Shi et al.   Oncotarget

Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling

(2015) Yang Cao et al.   BMC CANCER

Naphthazarin enhances ionizing radiation-induced cell cycle arrest and apoptosis in human breast cancer cells

(2015) MIN YOUNG KIM et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Qualitative and Quantitative Analysis of ROS-Mediated Oridonin-Induced Oesophageal Cancer KYSE-150 Cell Apoptosis by Atomic Force Microscopy

(2015) Jiang Pi et al.   PLoS One

Oridonin inhibits mTOR signaling and the growth of lung cancer tumors

(2014) Yan-Yan Wang et al.   ANTI-CANCER DRUGS

Altering the Response to Radiation: Sensitizers and Protectors

(2014) Deborah E. Citrin et al.   SEMINARS IN ONCOLOGY

Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway

(2014) Hua Liu et al.   TUMOR BIOLOGY

OpenComet: An automated tool for comet assay image analysis

(2014) Benjamin M. Gyori et al.   Redox Biology

Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells

(2013) Shengpeng Wang et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells

(2013) HONGMEI LUO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells

(2013) Ying Liu et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway

(2013) Ke-Wang Sun   WORLD JOURNAL OF GASTROENTEROLOGY

Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway

(2012) Yuan-chao Ye et al.   ACTA PHARMACOLOGICA SINICA

Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway

(2012) Yong Guo et al.   CANCER BIOLOGY & THERAPY

Oridonin Up-regulates Expression of P21 and Induces Autophagy and Apoptosis in Human Prostate Cancer Cells

(2012) Xiang Li et al.   International Journal of Biological Sciences

Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway

(2012) HE-QI BU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy

(2011) Heekyoung Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status

(2010) Nagata   INTERNATIONAL JOURNAL OF ONCOLOGY

Terameprocol (Tetra-O-Methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-Mediated Survivin Transcription, Induces Radiosensitization in Non-small Cell Lung Carcinoma

(2010) Yunguang Sun et al.   Journal of Thoracic Oncology

Improving Radiation Conformality in the Treatment of Non–Small-Cell Lung Cancer

(2010) Joe Y. Chang et al.   SEMINARS IN RADIATION ONCOLOGY

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines

(2008) T. Iwasa et al.   CLINICAL CANCER RESEARCH